BioSig Technologies Files 8-K
Ticker: STEX · Form: 8-K · Filed: Aug 13, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Aug 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $25,000,000, $50,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financials
TL;DR
BioSig filed an 8-K on Aug 13, 2025, for a material agreement and financials.
AI Summary
BioSig Technologies, Inc. filed an 8-K on August 13, 2025, reporting an entry into a material definitive agreement and financial statements. The filing does not contain specific details about the agreement or financial figures within the provided text.
Why It Matters
This filing indicates BioSig Technologies has entered into a significant agreement and is providing updated financial information, which could impact investors' understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for a material agreement and financial statements, with no immediate negative or positive indicators in the provided text.
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- August 13, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by BioSig Technologies?
The provided text states that BioSig Technologies, Inc. entered into a material definitive agreement, but does not specify the details of this agreement.
What financial statements are being reported in this 8-K filing?
The filing indicates that financial statements are being reported, but the specific content or period covered by these statements is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on August 13, 2025.
What is BioSig Technologies, Inc.'s principal executive office address?
BioSig Technologies, Inc.'s principal executive offices are located at 12424 Wilshire Blvd, Suite 745, Los Angeles, California 90025.
What is the SEC file number for BioSig Technologies, Inc.?
The SEC file number for BioSig Technologies, Inc. is 001-38659.
Filing Stats: 627 words · 3 min read · ~2 pages · Grade level 13.3 · Accepted 2025-08-13 14:29:39
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM The Nasdaq Capital M
- $25,000,000 — le debenture in the principal amount of $25,000,000, a second secured convertible debenture
- $50,000,000 — an aggregate principal amount of up to $50,000,000 to be issued upon mutual agreement of t
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex10-1.htm (EX-10.1) — 35KB
- 0001641172-25-023406.txt ( ) — 244KB
- bsgm-20250813.xsd (EX-101.SCH) — 3KB
- bsgm-20250813_lab.xml (EX-101.LAB) — 33KB
- bsgm-20250813_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: August 13, 2025 By: /s/ Henry McPhie Name: Henry McPhie Title: Chief Executive Officer